.Bristol Myers Squibb has actually had a whiplash change of mind on its own BCMA bispecific T-cell e...
.Charles Baum, M.D., Ph.D., who managed Mirati Therapies' $ 5.8 billion sale to Bristol Myers Squibb...
.After reaching out to greater than 200 firms to companion a Tourette syndrome therapy that presente...
.Novartis has actually had some rotten luck with bispecific antitoxins previously, yet judging by th...
.Pinetree Therapies will definitely help AstraZeneca vegetation some plants in its pipe along with a...
.GRO Biosciences has ended the week along with an extra $60.3 million in the bank, which the healthy...
.Invite to recently's Chutes & Ladders, our summary of considerable leadership hirings, shootings...